DNA-Encoded Neoantigen Vaccines Induce Robust Immunity in Preclinical Models & Clinical Studies
- VB10.NEO induces strong immunity and tumour protection in preclinical studies
- Streamlined manufacturing process to reduce turnaround time
- Robust immunity in advanced cancer patients highlights DNA-encoded neoantigen vaccine potency